drug · small molecule
patient view →treprostinil
Phase 3updated 2mo agoby $UTHR UNITED THERAPEUTICS Corp🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for recurrent thrombophlebitis and pulmonary arterial hypertension and 16 investigational indications.
targets
Prostacyclin receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that